Evidence map›Paper›PMID 35222231›Full record

ArticleFrontiers in neurology2021

Autoimmune Encephalitis in Long-Standing Schizophrenia: A Case Report.

Amy Vaux, Karen Robinson, Burcu Saglam, Nathan Cheuk, Trevor Kilpatrick, Andrew Evans, Mastura Monif

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amy VauxDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Karen RobinsonDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Burcu SaglamDepartment of Psychiatry, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Nathan CheukDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Trevor KilpatrickDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Andrew EvansDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Mastura MonifDepartment of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia.
The Royal Melbourne Hospital · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-N-methyl-D-aspartate (NMDA) receptor antibody (anti-NMDAR Ab)-mediated encephalitis is an autoimmune disorder involving the production of antibodies against NMDARs in the central nervous system that leads to neurological or psychiatric dysfunction. Initially described as a paraneoplastic syndrome in young women with teratomas, increased testing has found it to be a heterogeneous condition that affects both the sexes with varying clinical manifestations, severity, and aetiology. This case report describes a 67-year-old man with a 40-year history of relapsing, severe, treatment-refractory schizophrenia. Due to the worsening of his condition during a prolonged inpatient admission for presumed relapse of psychosis, a revisit of the original diagnosis was considered with extensive investigations performed including an autoimmune panel. This revealed anti-NMDAR Abs in both the serum and cerebrospinal fluid on two occasions. Following treatment with intravenous immunoglobulin and methylprednisolone, he demonstrated rapid symptom improvement. This is a rare case of a long-standing psychiatric presentation with a preexisting diagnosis of schizophrenia subsequently found to have anti-NMDAR Ab-mediated encephalitis. Whether the case is one of initial NMDAR encephalitis vs. overlap syndrome is unknown. Most importantly, this case highlights the need for vigilance and balanced consideration for treatment in cases of long-standing psychiatric presentation where the case remains treatment refractory to antipsychotics or when atypical features including seizures and autonomic dysfunction or focal neurology are observed.

Indexed as

autoimmune encephalitiscase reportchronic schizophreniadiagnostic dilemmaneuropsychiatric disordersNMDA antibodyNMDA encephalitis

Identifiers

PMID35222231
PMCPMC8873086
OpenAlexW4211153436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.